Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is compliance with antiviral therapy for chronic hepatitis C lower in intravenous drug users?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. (No authors listed) (2003) NIH Consensus Statement on Management of Hepatitis C: 2002 NIH Consens State Sci Statements 19: 1–46

  2. Backmund M et al. (2003) Hepatitis C virus infection in injection drug users in Bavaria: risk factors for seropositivity. Eur J Epidemiol 18: 563–538

    Article  Google Scholar 

  3. Sylvestre DL (2005) Treating hepatitis C virus infection in active substance users. Clin Infect Dis 40 (Suppl 5): S321–S324

    Article  Google Scholar 

  4. Schaefer M et al. (2004) Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction 99: 1167–1175

    Article  Google Scholar 

  5. Edlin BR (2002) Prevention and treatment of hepatitis C in injection drug users. Hepatology 36 (Suppl 1): S210–S219

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keyur Patel.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, K. Is compliance with antiviral therapy for chronic hepatitis C lower in intravenous drug users?. Nat Rev Gastroenterol Hepatol 3, 368–369 (2006). https://doi.org/10.1038/ncpgasthep0547

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0547

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing